Trials / Unknown
UnknownNCT02852096
Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
One paraffin block is routinely used for Human Epidermal Growth Factor Receptor 2 (Her2/neu) immunohistochemistry (IHC) assessment. Here, investigators investigated if picking two or multiple paraffin blocks for Her2/neu evaluation is an economical, efficient and practical method, which may reduce false-negativity of Her2/neu IHC assessment due to intratumoral heterogeneity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dual or Multiple Paraffin Blocks | Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks |
| OTHER | One Paraffin Blocks | Assessing Her2/Neu Expression in Gastric Cancer With One Tumor Tissue Paraffin Blocks |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2016-08-02
- Last updated
- 2017-11-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02852096. Inclusion in this directory is not an endorsement.